CLINICAL-PHARMACOLOGY OF HUMAN INSULIN

被引:54
作者
HEINEMANN, L
RICHTER, B
机构
[1] Nutrition/Metabolic Diseases Dept., Heinrich-Heine-Univ. of Dusseldorf, 40001 Dusseldorf
关键词
D O I
10.2337/diacare.16.3.90
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nowadays, human insulin is used daily by millions of diabetic patients. The biological effect of human insulin is comparable to that of porcine insulin. However, after subcutaneous injection, pharmacological and clinical studies showed pharmacokinetic and pharmacodynamic differences between human and animal insulins. Human insulin tends to have faster absorption and shorter duration of action compared with animal insulin. These differences are more pronounced and can be of clinical relevance with intermediate- and long-acting insulin preparations. Optimal metabolic control can be achieved with either human or highly purified animal insulin preparations, provided appropriate insulin replacement strategies are used.
引用
收藏
页码:90 / 100
页数:11
相关论文
共 86 条
[1]  
ADENIYIJONES ROC, 1983, DIABETES CARE, V6, P9
[2]   DOSE-RESPONSE RELATIONSHIP BETWEEN LYMPH INSULIN AND GLUCOSE-UPTAKE REVEALS ENHANCED INSULIN SENSITIVITY OF PERIPHERAL-TISSUES [J].
ADER, M ;
POULIN, RA ;
YANG, YJ ;
BERGMAN, RN .
DIABETES, 1992, 41 (02) :241-253
[3]   PATIENT EDUCATION AS THE BASIS FOR DIABETES CARE IN CLINICAL-PRACTICE AND RESEARCH [J].
ASSAL, JP ;
MUHLHAUSER, I ;
PERNET, A ;
GFELLER, R ;
JORGENS, V ;
BERGER, M .
DIABETOLOGIA, 1985, 28 (08) :602-613
[4]  
BAKER RS, 1981, LANCET, V2, P1139
[5]   KINETICS AND METABOLIC-ACTIVITY OF BIOSYNTHETIC NPH INSULIN EVALUATED BY THE GLUCOSE CLAMP TECHNIQUE [J].
BENEDETTI, MM ;
BUETI, A ;
MANNINO, D ;
BELLOMO, G ;
ANTONELLA, MA ;
CALABRESE, G ;
ZEGA, G ;
BRUNETTI, P .
DIABETES CARE, 1984, 7 (02) :132-136
[6]   ABSORPTION KINETICS AND BIOLOGIC EFFECTS OF SUBCUTANEOUSLY INJECTED INSULIN PREPARATIONS [J].
BERGER, M ;
CUPPERS, HJ ;
HEGNER, H ;
JORGENS, V ;
BERCHTOLD, P .
DIABETES CARE, 1982, 5 (02) :77-91
[7]   ABSORPTION KINETICS OF SUBCUTANEOUSLY INJECTED INSULIN - EVIDENCE FOR DEGRADATION AT THE INJECTION SITE [J].
BERGER, M ;
HALBAN, PA ;
GIRARDIER, L ;
SEYDOUX, J ;
OFFORD, RE ;
RENOLD, AE .
DIABETOLOGIA, 1979, 17 (02) :97-99
[8]  
BILO HJG, 1987, DIABETES RES CLIN EX, V4, P39
[9]   INSULIN CONCENTRATIONS AND TIME-ACTION PROFILES OF 3 DIFFERENT INTERMEDIATE-ACTING INSULIN PREPARATIONS IN NON-DIABETIC VOLUNTEERS UNDER GLUCOSE-CONTROLLED GLUCOSE-INFUSION TECHNIQUE [J].
BOTTERMANN, P ;
GYARAM, H ;
WAHL, K ;
ERMLER, R ;
LEBENDER, A .
DIABETES CARE, 1982, 5 :43-52
[10]   PHARMACOKINETICS OF BIOSYNTHETIC HUMAN INSULIN AND CHARACTERISTICS OF ITS EFFECT [J].
BOTTERMANN, P ;
GYARAM, H ;
WAHL, K ;
ERMLER, R ;
LEBENDER, A .
DIABETES CARE, 1981, 4 (02) :168-169